Pharmadrug Inc logo

Pharmadrug Inc

NEW
FRA:G11 (Canada)  
€ 0.015 +0.014 (+2800%) Mar 28
At Loss
Market Cap:
€ 1.05M ($ 1.14M)
Enterprise V:
€ 1.98M ($ 2.15M)
Volume:
4.38K
Avg Vol (2M):
8.44K
Trade In:
What is a stock summary page? Click here for an overview.

Business Description

Description
Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The Company's operations comprise of the corporate division in Canada. Geographically, it operates in Germany and Canada.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.09
Equity-to-Asset -1.93
Debt-to-Equity -0.95
Debt-to-EBITDA -0.1
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -5.6
3-Year EPS without NRI Growth Rate 48.3
3-Year FCF Growth Rate 48.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 96.68
9-Day RSI 87.02
14-Day RSI 72.2
3-1 Month Momentum % 233.33
6-1 Month Momentum % 25
12-1 Month Momentum % -67.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.1
Quick Ratio 0.1
Cash Ratio 0.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -36.7
Shareholder Yield % -18.18

Profitability Rank

Name Current Vs Industry Vs History
ROE % -3252.35
ROA % -417.45
ROIC % -26.69
3-Year ROIIC % -33.82
ROCE % -1644.2

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.22
EV-to-EBITDA -0.22
EV-to-FCF -2.92
Price-to-GF-Value 0.48
Earnings Yield (Greenblatt) % -448.8
FCF Yield % -64.05

Financials

FRA:G11's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Pharmadrug Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.154
Beta -1.36
3-Year Sharpe Ratio 0.79
3-Year Sortino Ratio 3.91
Volatility % 849.42
14-Day RSI 72.2
14-Day ATR (€) 0.002398
20-Day SMA (€) 0.001575
12-1 Month Momentum % -67.74
52-Week Range (€) 0.0005 - 0.032
Shares Outstanding (Mil) 107.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pharmadrug Inc Filings

Filing Date Document Date Form
No Filing Data

Pharmadrug Inc Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

Pharmadrug Inc Frequently Asked Questions

What is Pharmadrug Inc(FRA:G11)'s stock price today?
The current price of FRA:G11 is €0.01. The 52 week high of FRA:G11 is €0.03 and 52 week low is €0.00.
When is next earnings date of Pharmadrug Inc(FRA:G11)?
The next earnings date of Pharmadrug Inc(FRA:G11) is .
Does Pharmadrug Inc(FRA:G11) pay dividends? If so, how much?
Pharmadrug Inc(FRA:G11) does not pay dividend.

Press Release

Subject Date
No Press Release